Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

Abstract Objectives To investigate the incidence of pneumocystis pneumonia (PCP) and its risk factors in patients with rheumatic disease receiving non-high-dose steroid treatment, along with the risks and benefits of PCP prophylaxis. Methods This study included 28,292 treatment episodes with prolong...

Full description

Bibliographic Details
Main Authors: Jun Won Park, Jeffrey R. Curtis, Min Jung Kim, Hajeong Lee, Yeong Wook Song, Eun Bong Lee
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Arthritis Research & Therapy
Subjects:
Pneumocystis pneumonia
Glucocorticoids
Trimethoprim–sulfamethoxazole
Prophylaxis
Online Access:http://link.springer.com/article/10.1186/s13075-019-1996-6

Internet

http://link.springer.com/article/10.1186/s13075-019-1996-6

Similar Items